Inclusion in a new indication: local symptomatic treatment of lower limb spasticity.
-
Clinical Benefit
Substantial
Substantial.
Clinical Added Value
no clinical added value
On the basis of available data, DYSPORT does not offer any improvement in actual benefit (no IAB, level V) compared with BOTOX in the local symptomatic treatment of lower limb spasticity in children aged 2 years and over.
Listen
